An analysis of ischemic stroke patients with elevated blood pressure from the China Antihypertensive Trial in Acute Ischemic Stroke (CATIS) showed that raised NT-proBNP levels increased the risk of poor functional outcomes and other composite endpoints, including mortality and vascular events at 1 year18. Here, NPPB is linked to ischemic stroke.